Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 4.241
Filtrer
1.
Gen Physiol Biophys ; 43(4): 321-333, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-38953574

RÉSUMÉ

Vitiligo is featured by manifestation of white maculae and primarily results from oxidative stress. Sphingosine kinase-1 (SPHK1) participates in oxidative stress. This paper was devised to explore the role of SPHK1 in vitiligo and to disclose the mechanism. PIG1 cell viability was appraised utilizing cell counting kit-8 assay while Western blot detected SPHK1 and four and a half LIM domains 2 (FHL2). The transduction efficacy of small interfering RNA (siRNA)-SPHK1, siRNA-FHL2 and pcDNA3.1 plasmid overexpressing FHL2 (Ov-FHL2) was checked using Western blot. Flow cytometry detected cell apoptotisis. Western blot detected mitochondrial cytochrome c (Mit-Cyt-c) and cytosolic cytochrome c (Cyto-Cyt-c). Dichloro-dihydro-fluorescein diacetate (DCFH-DA) detected reactive oxygen species (ROS) activity while oxidative stress markers were evaluated using corresponding assay kits. SPHK1 expression was discovered to be increased in hydrogen peroxide (H2O2)-challenged PIG1 cells and SPHK1 interference alleviated H2O2-challenged viability damage, apoptosis, oxidative stress and FHL2 expression in PIG1 cells. FHL2 depletion could suppress viability damage, apoptosis and oxidative stress in H2O2-challenged PIG1 cells. Rescue experiments demonstrated that the suppressive impacts of SPHK1 deficiency on PIG1 cell viability, apoptosis and oxidative stress induced by H2O2 were offset by FHL2 overexpression. Collectively, SPHK1 knockdown protected against vitiligo via the regulation of FHL2.


Sujet(s)
Survie cellulaire , Peroxyde d'hydrogène , Protéines à homéodomaine LIM , Mélanocytes , Stress oxydatif , Phosphotransferases (Alcohol Group Acceptor) , Stress oxydatif/effets des médicaments et des substances chimiques , Phosphotransferases (Alcohol Group Acceptor)/métabolisme , Phosphotransferases (Alcohol Group Acceptor)/génétique , Peroxyde d'hydrogène/métabolisme , Protéines à homéodomaine LIM/métabolisme , Protéines à homéodomaine LIM/génétique , Humains , Mélanocytes/métabolisme , Mélanocytes/effets des médicaments et des substances chimiques , Survie cellulaire/effets des médicaments et des substances chimiques , Apoptose/effets des médicaments et des substances chimiques , Facteurs de transcription/métabolisme , Facteurs de transcription/génétique , Protéines du muscle/métabolisme , Protéines du muscle/génétique , Lignée cellulaire
2.
Diagn Pathol ; 19(1): 92, 2024 Jul 03.
Article de Anglais | MEDLINE | ID: mdl-38961434

RÉSUMÉ

AIMS: Vitiligo is a chronic dermatological condition characterized by the progressive loss of melanocytes, for which traditional therapy has shown limited efficacy. This study aimed to establish a vitiligo model with easy operability, high repeatability, and stable depigmentation to provide a foundation for studying the pathogenesis and developing novel therapies for vitiligo. METHODS: (1) Establishing vitiligo model: Firstly, deliver B16F10 cells to the back skin of C57BL/6 J via intradermal injection (day 0), and the CD4 depletion antibody was injected intraperitoneally on day 4 and 10. Secondly, the melanoma was surgically removed on day 12. Thirdly, CD8 antibody was administered intraperitoneally every fourth day till day 30. (2) Identification of vitiligo model: H&E staining, immunohistochemistry, and immunofluorescence were used to detect the melanocytes. The melanin was detected by transmission electron microscopy (TEM), Lillie ferrous sulfate staining and L-DOPA staining. RESULTS: (1) The back skin and hair began to appear white on day 30. Melanin loss reached peak on day 60; (2) Hematoxylin and eosin (H&E) staining, immunohistochemistry and immunofluorescence results showed melanocytes were reduced. L-DOPA staining, Lillie ferrous sulfate staining and TEM results showed that melanin decreased in the epidermis. CONCLUSION: We successfully establishment a vitiligo mouse model which can be more capable to simulate the pathogenesis of human vitiligo and provide an important basis for the study of pathogenesis and therapy of vitiligo.


Sujet(s)
Modèles animaux de maladie humaine , Mélanocytes , Souris de lignée C57BL , Vitiligo , Animaux , Vitiligo/anatomopathologie , Vitiligo/métabolisme , Vitiligo/thérapie , Mélanocytes/anatomopathologie , Mélanocytes/métabolisme , Souris , Mélanines/métabolisme
3.
Skin Res Technol ; 30(6): e13772, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38899729

RÉSUMÉ

BACKGROUND: Transient Receptor Potential Mucolipin 1 (TRPML1) serves as a pivotal reactive oxygen species (ROS) sensor in cells, which is implicated in the regulation of autophagy. However, its function in melanocyte autophagy under oxidative stress remains elusive. METHODS: The expression and ion channel function of TRPML1 were investigated using immunofluorescence and calcium imaging in primary human melanocytes (MCs). After activating TRPML1 with MLSA1 (TRPML1 agonist), autophagy-related molecules were investigated via western blot. ROS level, apoptosis- and autophagy-related molecules were investigated after pretreatment with MLSA1. After interference with TRPML1 expression, mitochondrial structures were visualized by electron microscopy with hydrogen peroxide (H2O2)treatment. RESULTS: TRPML1 was expressed and functionally active in primary human MCs, and its activation promotes elevated expression of LC3-II and reduced apoptosis and ROS levels under oxidative stress. TRPML1 downregulation caused mitochondrial swelling and disruption of cristae structures under oxidative stress in primary human MCs. CONCLUSIONS: TRPML1 might mediate lysosomal autophagy in primary human MCs under oxidative stress, participating in mechanisms that maintain the oxidative and antioxidant systems in balance.


Sujet(s)
Mélanocytes , Stress oxydatif , Espèces réactives de l'oxygène , Canaux cationiques TRP , Humains , Apoptose , Autophagie , Calcium/métabolisme , Cellules cultivées , Peroxyde d'hydrogène/pharmacologie , Mélanocytes/métabolisme , Mitochondries/métabolisme , Espèces réactives de l'oxygène/métabolisme , Canaux cationiques TRP/métabolisme
4.
Int J Mol Sci ; 25(11)2024 May 29.
Article de Anglais | MEDLINE | ID: mdl-38892114

RÉSUMÉ

This study presents the effects of treating polystyrene (PS) cell culture plastic with oxidoreductase enzyme laccase and the catechol substrates caffeic acid (CA), L-DOPA, and dopamine on the culturing of normal human epidermal melanocytes (NHEMs) and human embryonal carcinoma cells (NTERA-2). The laccase-substrate treatment improved PS hydrophilicity and roughness, increasing NHEM and NTERA-2 adherence, proliferation, and NHEM melanogenesis to a level comparable with conventional plasma treatment. Cell adherence dynamics and proliferation were evaluated. The NHEM endpoint function was quantified by measuring melanin content. PS surfaces treated with laccase and its substrates demonstrated the forming of polymer-like structures. The surface texture roughness gradient and the peak curvature were higher on PS treated with a combination of laccase and substrates than laccase alone. The number of adherent NHEM and NTERA-2 was significantly higher than on the untreated surface. The proliferation of NHEM and NTERA-2 correspondingly increased on treated surfaces. NHEM melanin content was enhanced 6-10-fold on treated surfaces. In summary, laccase- and laccase-substrate-modified PS possess improved PS surface chemistry/hydrophilicity and altered roughness compared to untreated and plasma-treated surfaces, facilitating cellular adherence, subsequent proliferation, and exertion of the melanotic phenotype. The presented technology is easy to apply and creates a promising custom-made, substrate-based, cell-type-specific platform for both 2D and 3D cell culture.


Sujet(s)
Acides caféiques , Prolifération cellulaire , Dopamine , Laccase , Mélanines , Mélanocytes , Polystyrènes , Humains , Laccase/métabolisme , Mélanocytes/métabolisme , Mélanocytes/effets des médicaments et des substances chimiques , Prolifération cellulaire/effets des médicaments et des substances chimiques , Polystyrènes/composition chimique , Acides caféiques/pharmacologie , Acides caféiques/composition chimique , Dopamine/métabolisme , Mélanines/métabolisme , Adhérence cellulaire/effets des médicaments et des substances chimiques , Lévodopa/pharmacologie , Lévodopa/métabolisme , Lévodopa/composition chimique , Propriétés de surface , Lignée cellulaire tumorale , Cellules souches de carcinome embryonnaire/métabolisme , Cellules souches de carcinome embryonnaire/effets des médicaments et des substances chimiques
5.
Elife ; 132024 Jun 20.
Article de Anglais | MEDLINE | ID: mdl-38900147

RÉSUMÉ

Transport and localization of melanosome at the periphery region of melanocyte are depended on myosin-5a (Myo5a), which associates with melanosome by interacting with its adaptor protein melanophilin (Mlph). Mlph contains four functional regions, including Rab27a-binding domain, Myo5a GTD-binding motif (GTBM), Myo5a exon F-binding domain (EFBD), and actin-binding domain (ABD). The association of Myo5a with Mlph is known to be mediated by two specific interactions: the interaction between the exon-F-encoded region of Myo5a and Mlph-EFBD and that between Myo5a-GTD and Mlph-GTBM. Here, we identify a third interaction between Myo5a and Mlph, that is, the interaction between the exon-G-encoded region of Myo5a and Mlph-ABD. The exon-G/ABD interaction is independent from the exon-F/EFBD interaction and is required for the association of Myo5a with melanosome. Moreover, we demonstrate that Mlph-ABD interacts with either the exon-G or actin filament, but cannot interact with both of them simultaneously. Based on above findings, we propose a new model for the Mlph-mediated Myo5a transportation of melanosomes.


Sujet(s)
Protéines adaptatrices de la transduction du signal , Mélanosomes , Myosine de type V , Liaison aux protéines , Mélanosomes/métabolisme , Myosine de type V/métabolisme , Myosine de type V/génétique , Animaux , Souris , Protéines adaptatrices de la transduction du signal/métabolisme , Protéines adaptatrices de la transduction du signal/génétique , Humains , Chaînes lourdes de myosine/métabolisme , Chaînes lourdes de myosine/génétique , Mélanocytes/métabolisme
6.
Arch Dermatol Res ; 316(7): 401, 2024 Jun 15.
Article de Anglais | MEDLINE | ID: mdl-38878083

RÉSUMÉ

BACKGROUND: The adhesive properties of vitiligo melanocytes have decreased under oxidative stress., cytoskeleton proteins can control cell adhesion. Paeoniflorin (PF) was proved to resist hydrogen peroxide (H2O2)-induced oxidative stress in melanocytes via nuclear factorE2-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) pathway. OBJECTIVES: This study was to investigate whether PF exerts anti-oxidative effect through influencing cytoskeleton markers or potential signaling pathway. METHODS: Human Oxidative Stress Plus array was used to identify the differentially expressed genes between H2O2 + PF group and H2O2 only group, in PIG1 and PIG3V melanocyte cell lines respectively. Western blotting was used to verify the PCR array results and to test the protein expression levels of cytoskeleton markers including Ras homolog family member A (RhoA), Rho-associated kinase 1 (ROCK1) and antioxidative marker Nrf2. Small interfering RNA was used to knock down PDZ and LIM domain 1 (PDLIM1). RESULTS: PF increased the expressions of PDLIM1, RhoA and ROCK1 in H2O2-induced PIG1, in contrast, decreased the expressions of PDLIM1 and ROCK1 in H2O2-induced PIG3V. Knockdown of PDLIM1 increased the expressions of RhoA and Nrf2 in PF-pretreated H2O2-induced PIG1, and ROCK1 and Nrf2 in PF-pretreated H2O2-induced PIG3V. CONCLUSIONS: PF regulates RhoA/ROCK1 and Nrf2 pathways in PDLIM1-dependent or independent manners in H2O2-induced melanocytes. In PIG1, PF promotes PDLIM1 to inhibit RhoA/ROCK1 pathway or activates Nrf2/HO-1 pathway, separately. In PIG3V, PF directly downregulates ROCK1 in PDLIM1-independent manner or upregulates Nrf2 dependent of PDLIM1.


Sujet(s)
Glucosides , Peroxyde d'hydrogène , Protéines à domaine LIM , Mélanocytes , Monoterpènes , Facteur-2 apparenté à NF-E2 , Stress oxydatif , Transduction du signal , rho-Associated Kinases , Protéine G RhoA , Facteur-2 apparenté à NF-E2/métabolisme , rho-Associated Kinases/métabolisme , Mélanocytes/effets des médicaments et des substances chimiques , Mélanocytes/métabolisme , Humains , Glucosides/pharmacologie , Stress oxydatif/effets des médicaments et des substances chimiques , Protéine G RhoA/métabolisme , Peroxyde d'hydrogène/métabolisme , Transduction du signal/effets des médicaments et des substances chimiques , Protéines à domaine LIM/métabolisme , Protéines à domaine LIM/génétique , Monoterpènes/pharmacologie , Lignée cellulaire
7.
Int J Mol Sci ; 25(11)2024 May 29.
Article de Anglais | MEDLINE | ID: mdl-38892131

RÉSUMÉ

Petanin, an acylated anthocyanin from the Solanaceae family, shows potential in tyrosinase inhibitory activity and anti-melanogenic effects; however, its mechanism remains unclear. Therefore, to investigate the underlying mechanism of petanin's anti-melanogenic effects, the enzyme activity, protein expression and mRNA transcription of melanogenic and related signaling pathways in zebrafish using network pharmacology, molecular docking and molecular dynamics simulation were combined for analysis. The results showed that petanin could inhibit tyrosinase activity and melanogenesis, change the distribution and arrangement of melanocytes and the structure of melanosomes, reduce the activities of catalase (CAT) and peroxidase (POD) and enhance the activity of glutathione reductase (GR). It also up-regulated JNK phosphorylation, inhibited ERK/RSK phosphorylation and down-regulated CREB/MITF-related protein expression and mRNA transcription. These results were consistent with the predictions provided through network pharmacology and molecular docking. Thus, petanin could inhibit the activity of tyrosinase and the expression of tyrosinase by inhibiting and negatively regulating the tyrosinase-related signaling pathway ERK/CREB/MITF through p-JNK. In conclusion, petanin is a good tyrosinase inhibitor and anti-melanin natural compound with significant market prospects in melanogenesis-related diseases and skin whitening cosmetics.


Sujet(s)
Mélanines , Simulation de docking moléculaire , Danio zébré , Animaux , Danio zébré/métabolisme , Mélanines/métabolisme , Mélanines/biosynthèse , Phosphorylation , Système de signalisation des MAP kinases/effets des médicaments et des substances chimiques , Transduction du signal/effets des médicaments et des substances chimiques , Protéine de liaison à l'élément de réponse à l'AMP cyclique/métabolisme , Monophenol monooxygenase/métabolisme , Monophenol monooxygenase/antagonistes et inhibiteurs , Facteur de transcription associé à la microphtalmie/métabolisme , Facteur de transcription associé à la microphtalmie/génétique , Mélanocytes/métabolisme , Mélanocytes/effets des médicaments et des substances chimiques
8.
Front Biosci (Landmark Ed) ; 29(6): 230, 2024 Jun 24.
Article de Anglais | MEDLINE | ID: mdl-38940034

RÉSUMÉ

BACKGROUND: Existing animal models for testing therapeutics in the skin are limited. Mouse and rat models lack similarity to human skin in structure and wound healing mechanism. Pigs are regarded as the best model with regards to similarity to human skin; however, these studies are expensive, time-consuming, and only small numbers of biologic replicates can be obtained. In addition, local-regional effects of treating wounds that are closely adjacent to one-another with different treatments make assessment of treatment effectiveness difficult in pig models. Therefore, here, a novel nude mouse model of xenografted porcine hypertrophic scar (HTS) cells was developed. This model system was developed to test if supplying hypo-pigmented cells with exogenous alpha melanocyte stimulating hormone (α-MSH) will reverse pigment loss in vivo. METHODS: Dyschromic HTSs were created in red Duroc pigs. Epidermal scar cells (keratinocytes and melanocytes) were derived from regions of hyper-, hypo-, or normally pigmented scar or skin and were cryopreserved. Dermal fibroblasts (DFs) were isolated separately. Excisional wounds were created on nude mice and a grafting dome was placed. DFs were seeded on day 0 and formed a dermis. On day 3, epidermal cells were seeded onto the dermis. The grafting dome was removed on day 7 and hypo-pigmented xenografts were treated with synthetic α-MSH delivered with microneedling. On day 10, the xenografts were excised and saved. Sections were stained using hematoxylin and eosin hematoxylin and eosin (H&E) to assess xenograft structure. RNA was isolated and quantitative real-time polymerase chain reaction (qRT-PCR) was performed for melanogenesis-related genes TYR, TYRP1, and DCT. RESULTS: The seeding of HTSDFs formed a dermis that is similar in structure and cellularity to HTS dermis from the porcine model. When hyper-, hypo-, and normally-pigmented epidermal cells were seeded, a fully stratified epithelium was formed by day 14. H&E staining and measurement of the epidermis showed the average thickness to be 0.11 ± 0.07 µm vs. 0.06 ± 0.03 µm in normal pig skin. Hypo-pigmented xenografts that were treated with synthetic α-MSH showed increases in pigmentation and had increased gene expression of TYR, TYRP1, and DCT compared to untreated controls (TYR: 2.7 ± 1.1 vs. 0.3 ± 1.1; TYRP1: 2.6 ± 0.6 vs. 0.3 ± 0.7; DCT 0.7 ± 0.9 vs. 0.3 ± 1-fold change from control; n = 3). CONCLUSIONS: The developed nude mouse skin xenograft model can be used to study treatments for the skin. The cells that can be xenografted can be derived from patient samples or from pig samples and form a robust dual-skin layer containing epidermis and dermis that is responsive to treatment. Specifically, we found that hypo-pigmented regions of scar can be stimulated to make melanin by synthetic α-MSH in vivo.


Sujet(s)
Cicatrice hypertrophique , Modèles animaux de maladie humaine , Souris nude , Animaux , Cicatrice hypertrophique/thérapie , Cicatrice hypertrophique/anatomopathologie , Souris , Suidae , Hormone mélanotrope alpha , Humains , Peau/anatomopathologie , Fibroblastes/métabolisme , Mélanocytes/métabolisme , Kératinocytes/métabolisme , Transplantation hétérologue , Cicatrisation de plaie , Pigmentation de la peau
9.
Int J Mol Sci ; 25(12)2024 Jun 20.
Article de Anglais | MEDLINE | ID: mdl-38928474

RÉSUMÉ

Chitosan is a natural polymer with numerous biomedical applications. The cellular activity of chitosan has been studied in various types of cancer, including melanoma, and indicates that these molecules can open new perspectives on antiproliferative action and anticancer therapy. This study analyzes how different chitosan conformations, such as α-chitosan (CH) or ß-oligochitosan (CO), with various degrees of deacetylation (DDA) and molar mass (MM), both in different concentrations and in CH-CO mixtures, influence the cellular processes of SK-MEL-28 melanocytes, to estimate the reactivity of these cells to the applied treatments. The in vitro evaluation was carried out, aiming at the cellular metabolism (MTT assay), cellular morphology, and chitinase-like glycoprotein YKL-40 expression. The in vitro effect of the CH-CO mixture application on melanocytes is obvious at low concentrations of α-chitosan/ß-oligochitosan (1:2 ratio), with the cell's response supporting the hypothesis that ß-oligo-chitosan amplifies the effect. This oligochitosan mixture, favored by the ß conformation and its small size, penetrates faster into the cells, being more reactive when interacting with some cellular components. Morphological effects expressed by the loss of cell adhesion and the depletion of YKL-40 synthesis are significant responses of melanocytes. ß-oligochitosan (1.5 kDa) induces an extension of cytophysiological effects and limits the cell viability compared to α-chitosan (400-900 kDa). Statistical analysis using multivariate techniques showed differences between the CH samples and CH-CO mixtures.


Sujet(s)
Chitine , Protéine-1 similaire à la chitinase-3 , Chitosane , Mélanocytes , Oligosaccharides , Chitosane/composition chimique , Chitosane/pharmacologie , Mélanocytes/effets des médicaments et des substances chimiques , Mélanocytes/métabolisme , Humains , Chitine/analogues et dérivés , Chitine/pharmacologie , Chitine/composition chimique , Oligosaccharides/pharmacologie , Protéine-1 similaire à la chitinase-3/métabolisme , Survie cellulaire/effets des médicaments et des substances chimiques , Prolifération cellulaire/effets des médicaments et des substances chimiques , Lignée cellulaire tumorale , Mélanome/traitement médicamenteux , Mélanome/métabolisme , Mélanome/anatomopathologie
10.
Arch Dermatol Res ; 316(6): 225, 2024 May 24.
Article de Anglais | MEDLINE | ID: mdl-38787453

RÉSUMÉ

Myosin Va (Myo Va) is one of three protein complexes involved in melanosome transport. In this study, we identified BMP-2 as an up-regulator of Myo Va expression using 2-methyl-naphtho[1,2,3-de]quinolin-8-one (MNQO). Our results showed that MNQO reduced the mRNA and protein expression of Myo Va and BMP-2 in melanocytes. Knockdown of BMP-2 by siRNA also affected Myo Va mRNA and protein expression, confirming that MNQO regulates Myo Va through BMP-2. Furthermore, phosphorylation of Smad1/5/8 by BMP2 treatment confirmed that the BMP-2/Smad signaling pathway regulates Myo Va expression in Melan-a melanocytes. Smad-binding elements were found in the Myo Va promoter and phosphorylated Smad1/5/8 bind directly to the Myo Va promoter to activate Myo Va transcription and BMP-2 enhances this binding. These findings provide insight into a new role for BMP-2 in Melan-a melanocytes and a mechanism of regulation of Myo Va expression that may be beneficial in the treatment of albinism or hyperpigmentation disorders.


Sujet(s)
Protéine morphogénétique osseuse de type 2 , Mélanocytes , Chaînes lourdes de myosine , Myosine de type V , Transduction du signal , Myosine de type V/métabolisme , Myosine de type V/génétique , Mélanocytes/métabolisme , Protéine morphogénétique osseuse de type 2/métabolisme , Protéine morphogénétique osseuse de type 2/génétique , Chaînes lourdes de myosine/métabolisme , Chaînes lourdes de myosine/génétique , Humains , Protéines Smad/métabolisme , Régions promotrices (génétique)/génétique , Phosphorylation , Souris , Animaux , Régulation de l'expression des gènes
11.
Mol Biol Rep ; 51(1): 650, 2024 May 11.
Article de Anglais | MEDLINE | ID: mdl-38734811

RÉSUMÉ

BACKGROUND: Vitiligo is a common autoimmune skin disease. Capsaicin has been found to exert a positive effect on vitiligo treatment, and mesenchymal stem cells (MSCs) are also confirmed to be an ideal cell type. This study aimed to explore the influence of capsaicin combined with stem cells on the treatment of vitiligo and to confirm the molecular mechanism of capsaicin combined with stem cells in treating vitiligo. METHODS AND RESULTS: PIG3V cell proliferation and apoptosis were detected using CCK-8 and TUNEL assays, MitoSOX Red fluorescence staining was used to measure the mitochondrial ROS level, and JC-1 staining was used to detect the mitochondrial membrane potential. The expression of related genes and proteins was detected using RT‒qPCR and Western blotting. Coimmunoprecipitation was used to analyze the protein interactions between HSP70 and TLR4 or between TLR4 and mTOR. The results showed higher expression of HSP70 in PIG3V cells than in PIG1 cells. The overexpression of HSP70 reduced the proliferation of PIG3V cells, promoted apoptosis, and aggravated mitochondrial dysfunction and autophagy abnormalities. The expression of HSP70 could be inhibited by capsaicin combined with MSCs, which increased the levels of Tyr, Tyrp1 and DCT, promoted the proliferation of PIG3V cells, inhibited apoptosis, activated autophagy, and improved mitochondrial dysfunction. In addition, capsaicin combined with MSCs regulated the expression of TLR4 through HSP70 and subsequently affected the mTOR/FAK signaling pathway CONCLUSIONS: Capsaicin combined with MSCs inhibits TLR4 through HSP70, and the mTOR/FAK signaling pathway is inhibited to alleviate mitochondrial dysfunction and autophagy abnormalities in PIG3V cells.


Sujet(s)
Apoptose , Capsaïcine , Prolifération cellulaire , Protéines du choc thermique HSP70 , Mélanocytes , Mitochondries , Transduction du signal , Sérine-thréonine kinases TOR , Récepteur de type Toll-4 , Vitiligo , Humains , Apoptose/effets des médicaments et des substances chimiques , Autophagie/effets des médicaments et des substances chimiques , Capsaïcine/pharmacologie , Lignée cellulaire , Prolifération cellulaire/effets des médicaments et des substances chimiques , Protéines du choc thermique HSP70/effets des médicaments et des substances chimiques , Protéines du choc thermique HSP70/métabolisme , Mélanocytes/métabolisme , Mélanocytes/effets des médicaments et des substances chimiques , Potentiel de membrane mitochondriale/effets des médicaments et des substances chimiques , Cellules souches mésenchymateuses/métabolisme , Cellules souches mésenchymateuses/effets des médicaments et des substances chimiques , Mitochondries/métabolisme , Mitochondries/effets des médicaments et des substances chimiques , Transduction du signal/effets des médicaments et des substances chimiques , Récepteur de type Toll-4/effets des médicaments et des substances chimiques , Récepteur de type Toll-4/métabolisme , Sérine-thréonine kinases TOR/effets des médicaments et des substances chimiques , Sérine-thréonine kinases TOR/métabolisme , Vitiligo/métabolisme , Vitiligo/traitement médicamenteux , Focal adhesion kinase 1/effets des médicaments et des substances chimiques , Focal adhesion kinase 1/métabolisme
12.
J Dermatol Sci ; 114(3): 115-123, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38806323

RÉSUMÉ

BACKGROUND: Vitiligo is a skin disorder with melanocyte destruction caused by complex interplay between multiple genetic and environmental factors. Recent studies have suggested DNA methylation is involved in the melanocyte damage, but the underlying mechanism remains unknown. OBJECTIVE: To explore the abnormal DNA methylation patterns in vitiligo lesional and nonlesional skin, and the mechanism of DNA methylation involved in vitiligo pathogenesis. METHODS: Initially, the genome-wide aberrant DNA methylation profiles in lesional and nonlesional skin of vitiligo were detect via Illumina methylation EPIC 850k Beadchip. Subsequently, a comprehensive analysis was conduct to investigate the genomic characteristics of differentially methylated regions (DMRs). Furthermore, the effects of key aberrant methylated genes on cell apoptosis and function of both melanocytes and keratinocytes were further identified and validated by western bloting, ELISA, and immunofluorescence. RESULTS: Compared with nonlesional skins, we discovered 79 significantly differentially methylated CpG sites in vitiligo lesions. These DMRs were mainly located in the gene body and the TS1500 region. Annexin A2 receptor (ANXA2R), a crucial gene in cell apoptosis, was hypermethylated in vitiligo lesions. Furthermore, we showed that ANXA2R displayed hypermethylation and low expression levels in both keratinocytes and melanocytes of vitiligo patients, and the hypermethylated-triggered downregulation of ANXA2R under oxidative stress induced melanocyte apoptosis, and inhibited the secretion of stem cell factor (SCF) from keratinocytes thus impaired the survival of melanocytes. CONCLUSIONS: Our study illustrates the DNA methylation modification in vitiligo, and further demonstrates the molecular mechanism of hypermethylated ANXA2R in the dysfunction of melanocytes under oxidative stress.


Sujet(s)
Apoptose , Méthylation de l'ADN , Kératinocytes , Mélanocytes , Stress oxydatif , Vitiligo , Humains , Vitiligo/génétique , Vitiligo/anatomopathologie , Mélanocytes/métabolisme , Mélanocytes/anatomopathologie , Apoptose/génétique , Kératinocytes/métabolisme , Adulte , Mâle , Femelle , Ilots CpG/génétique , Peau/anatomopathologie , Peau/métabolisme , Jeune adulte , Études cas-témoins , Adulte d'âge moyen
13.
Pigment Cell Melanoma Res ; 37(4): 514-529, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-38705722

RÉSUMÉ

Epidermal melanin unit integrity is crucial for skin homeostasis and pigmentation. Epidermal growth factor (EGF) receptor (EGFR) is a pivotal player in cell growth, wound healing, and maintaining skin homeostasis. However, its influence on skin pigmentation is relatively unexplored. This study investigates the impact and underlying mechanisms of EGFR inhibitors on skin pigmentation. We evaluated EGF and EGFR expression in various skin cells using quantitative real-time PCR, Western blot, and immunofluorescence. EGF and EGFR were predominantly expressed in epidermal keratinocytes, and treatment with the EGFR tyrosine kinase inhibitors (EGFR-TKIs) gefitinib and PD153035 significantly increased stem cell factor (SCF) and endothelin-1 (ET-1) expression in cultured keratinocytes. Enhanced melanocyte migration and proliferation were observed in co-culture, as evidenced by time-lapse live imaging and single-cell tracking assays. Furthermore, topical application of gefitinib to guinea pig dorsal skin induced increased pigmentation and demonstrated efficacy in mitigating rhododendrol-induced leukoderma. Suppression of EGF signaling indirectly enhanced skin pigmentation by upregulating SCF and ET-1 in epidermal keratinocytes. This novel mechanism highlights the pivotal role of EGF signaling in regulating skin pigmentation, and topical EGFR-TKI therapy at an appropriate dose may be a promising approach for depigmentation disorder management.


Sujet(s)
Récepteurs ErbB , Géfitinib , Hypopigmentation , Kératinocytes , Mélanines , Mélanocytes , Inhibiteurs de protéines kinases , Récepteurs ErbB/métabolisme , Animaux , Mélanines/métabolisme , Mélanines/biosynthèse , Humains , Inhibiteurs de protéines kinases/pharmacologie , Mélanocytes/effets des médicaments et des substances chimiques , Mélanocytes/métabolisme , Mélanocytes/anatomopathologie , Kératinocytes/effets des médicaments et des substances chimiques , Kératinocytes/métabolisme , Kératinocytes/anatomopathologie , Hypopigmentation/anatomopathologie , Hypopigmentation/traitement médicamenteux , Géfitinib/pharmacologie , Cochons d'Inde , Pigmentation de la peau/effets des médicaments et des substances chimiques , Facteur de croissance des cellules souches/métabolisme , Épiderme/effets des médicaments et des substances chimiques , Épiderme/anatomopathologie , Épiderme/métabolisme , Prolifération cellulaire/effets des médicaments et des substances chimiques , Mouvement cellulaire/effets des médicaments et des substances chimiques , Endothéline-1/métabolisme , Facteur de croissance épidermique/métabolisme , Facteur de croissance épidermique/pharmacologie , Quinazolines
14.
Ann Diagn Pathol ; 72: 152332, 2024 Oct.
Article de Anglais | MEDLINE | ID: mdl-38776734

RÉSUMÉ

Tubulin ß-3 staining pattern and staining intensity of 5-hydroxymethyl cytosine (5-hmC) are potential diagnostic and prognostic markers in melanocytic lesions that need further evaluation. Melanocytic nevi and primary cutaneous melanomas were immunohistochemically stained for tubulin-ß-3 and 5-hmC. Immunoreactivity and staining patterns were correlated with Breslow-thickness, clinical and pathological characteristics, and progression-free survival. Melanocytes showed positive tubulin ß-3 staining. However, in most nevi, tubulin ß-3 staining appeared as a gradient with intense cytoplasmic staining in cells of the superficial part of the lesion that faded to weak staining in the deep dermal part, while no gradient was found in deep penetrating nevi and melanomas. In 53 % of the melanomas, areas with loss of tubulin ß-3 staining were found. 5-hmC staining intensity was significantly higher in melanocytic nevi compared to melanomas. Breslow thickness in combination with low 5-hmC score and loss of tubulin-ß-3 staining was predictive for poor prognosis. As single markers, tubulin-ß-3 and 5-hmC can be useful to distinguish between melanocytic nevi and melanoma, but staining variability limits the use of 5-hmC. In melanomas measuring >1.5 mm, combination of low 5-hmC score and loss of tubulin-ß-3 staining may have prognostic value.


Sujet(s)
5-Méthyl-cytosine , Marqueurs biologiques tumoraux , Mélanome , Tumeurs cutanées , Tubuline , Humains , Mélanome/diagnostic , Mélanome/métabolisme , Mélanome/anatomopathologie , Marqueurs biologiques tumoraux/métabolisme , Marqueurs biologiques tumoraux/analyse , Pronostic , Mâle , Femelle , Tubuline/métabolisme , Tubuline/analyse , Tumeurs cutanées/diagnostic , Tumeurs cutanées/anatomopathologie , Tumeurs cutanées/métabolisme , Adulte d'âge moyen , 5-Méthyl-cytosine/analogues et dérivés , 5-Méthyl-cytosine/métabolisme , 5-Méthyl-cytosine/analyse , Sujet âgé , Adulte , Immunohistochimie/méthodes , Naevus pigmentaire/diagnostic , Naevus pigmentaire/anatomopathologie , Naevus pigmentaire/métabolisme , , Sujet âgé de 80 ans ou plus , Mélanocytes/anatomopathologie , Mélanocytes/métabolisme
15.
Toxicol In Vitro ; 98: 105844, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38740103

RÉSUMÉ

Streptomycin (STR) is an aminoglycoside antibiotic with a broad-spectrum of activity and ototoxic potential. The mechanism of STR-induced inner ear damage has not been fully elucidated. It was previously found that STR binds to melanin, which may result in the accumulation of the drug in melanin-containing tissues. Melanin pigment is present in various parts of the inner ear, including the cochlea and vestibular organ. The present study aimed to assess if streptomycin generates oxidative stress and affects melanogenesis in normal human melanocytes. Moreover the variation of free radical concentration in STR-treated melanocytes was examined by electron paramagnetic resonance spectroscopy (EPR). We found that STR decreases cell metabolic activity and reduces melanin content. The observed changes in the activity of antioxidant enzymes activity in HEMn-DPs treated with streptomycin may suggest that the drug affects redox homeostasis in melanocytes. In this work EPR study expanded knowledge about free radicals in interactions of STR and melanin in melanocytes. The results may help elucidate the mechanisms of STR toxicity on pigment cells, including melanin-producing cells in the inner ear. This is important because understanding the mechanism of STR-induced ototoxicity would be helpful in developing new therapeutic strategies to protect patients' hearing.


Sujet(s)
Antibactériens , Mélanines , Mélanocytes , Stress oxydatif , Streptomycine , Mélanines/métabolisme , Humains , Spectroscopie de résonance de spin électronique , Stress oxydatif/effets des médicaments et des substances chimiques , Mélanocytes/effets des médicaments et des substances chimiques , Mélanocytes/métabolisme , Streptomycine/toxicité , Antibactériens/toxicité , Cellules cultivées , Survie cellulaire/effets des médicaments et des substances chimiques , Radicaux libres/métabolisme , Lignée cellulaire
16.
Nat Commun ; 15(1): 4521, 2024 May 28.
Article de Anglais | MEDLINE | ID: mdl-38806452

RÉSUMÉ

Topologically associated domains (TADs) restrict promoter-enhancer interactions, thereby maintaining the spatiotemporal pattern of gene activity. However, rearrangements of the TADs boundaries do not always lead to significant changes in the activity pattern. Here, we investigated the consequences of the TAD boundaries deletion on the expression of developmentally important genes encoding tyrosine kinase receptors: Kit, Kdr, Pdgfra. We used genome editing in mice to delete the TADs boundaries at the Kit locus and characterized chromatin folding and gene expression in pure cultures of fibroblasts, mast cells, and melanocytes. We found that although Kit is highly active in both mast cells and melanocytes, deletion of the TAD boundary between the Kit and Kdr genes results in ectopic activation only in melanocytes. Thus, the epigenetic landscape, namely the mutual arrangement of enhancers and actively transcribing genes, is important for predicting the consequences of the TAD boundaries removal. We also found that mice without a TAD border between the Kit and Kdr genes have a phenotypic manifestation of the mutation - a lighter coloration. Thus, the data obtained shed light on the principles of interaction between the 3D chromatin organization and epigenetic marks in the regulation of gene activity.


Sujet(s)
Chromatine , Fibroblastes , Mastocytes , Mélanocytes , Protéines proto-oncogènes c-kit , Animaux , Protéines proto-oncogènes c-kit/génétique , Protéines proto-oncogènes c-kit/métabolisme , Souris , Mastocytes/métabolisme , Mélanocytes/métabolisme , Fibroblastes/métabolisme , Chromatine/métabolisme , Chromatine/génétique , Récepteur-2 au facteur croissance endothéliale vasculaire/génétique , Récepteur-2 au facteur croissance endothéliale vasculaire/métabolisme , Régions promotrices (génétique)/génétique , Éléments activateurs (génétique)/génétique , Récepteur au PDGF alpha/génétique , Récepteur au PDGF alpha/métabolisme , Épigenèse génétique , Locus génétiques , Souris de lignée C57BL , Spécificité d'organe/génétique , Édition de gène , Expression génique ectopique , Mâle
17.
Biosens Bioelectron ; 258: 116337, 2024 Aug 15.
Article de Anglais | MEDLINE | ID: mdl-38703495

RÉSUMÉ

Recruiting circulating cells based on interactions between surface receptors and corresponding ligands holds promise for capturing cells with specific adhesive properties. Our study investigates the adhesion of skin cells to specific lectins, particularly focusing on advancements in lectin-based biosensors with diagnostic potential. We explore whether we can successfully capture normal skin (melanocytes and keratinocytes) and melanoma (WM35, WM115, WM266-4) cells in a low-shear flow environment by coating surfaces with lectins. Specifically, we coated surfaces with Dolichos biflorus (DBA) and Maackia Amurensis (MAL) lectins, which were used to detect and capture specific skin cells from the flow of cell mixture. Alterations in glycan expression (confirmed by fluorescent microscopy) demonstrated that DBA binds predominantly to normal skin cells, while MAL interacts strongly with melanoma cells. Assessing adhesion under static and dynamic low-shear stress conditions (up to 30 mPa) underscores the reliability of DBA and MAL as markers for discriminating specific cell type. Melanocytes and keratinocytes adhere to DBA-coated surfaces, while melanoma cells prefer MAL-coated surfaces. A comprehensive analysis encompassing cell shape, cytoskeleton, and focal adhesions shows the independence of our approach from the inherent characteristics of cells, thus demonstrating its robustness. Our results carry practical implications for lectin-biosensor designs, emphasizing the significance of glycan-based discrimination of pathologically altered cells. Combined with microfluidics, it demonstrates the value of cell adhesion as a discriminant of cancer-related changes, with potential applications spanning diagnostics, therapeutic interventions, and advanced biomedical technologies.


Sujet(s)
Techniques de biocapteur , Adhérence cellulaire , Tumeurs cutanées , Humains , Techniques de biocapteur/méthodes , Techniques de biocapteur/instrumentation , Glycosylation , Tumeurs cutanées/anatomopathologie , Mélanome/anatomopathologie , Mélanome/diagnostic , Kératinocytes/cytologie , Peau/anatomopathologie , Peau/composition chimique , Lectines/composition chimique , Lectines/métabolisme , Lignée cellulaire tumorale , Mélanocytes/cytologie , Mélanocytes/métabolisme , Microfluidique/méthodes , Techniques d'analyse microfluidique/instrumentation
18.
Molecules ; 29(9)2024 Apr 30.
Article de Anglais | MEDLINE | ID: mdl-38731556

RÉSUMÉ

Red rice, a variety of pigmented grain, serves dual purposes as both a food and medicinal resource. In recent years, we have witnessed an increasing interest in the dermatological benefits of fermented rice extracts, particularly their whitening and hydrating effects. However, data on the skincare advantages derived from fermenting red rice with Aspergillus oryzae remain sparse. This study utilized red rice as a substrate for fermentation by Aspergillus oryzae, producing a substance known as red rice Aspergillus oryzae fermentation (RRFA). We conducted a preliminary analysis of RRFA's composition followed by an evaluation of its skincare potential through various in vitro tests. Our objective was to develop a safe and highly effective skincare component for potential cosmetic applications. RRFA's constituents were assessed using high-performance liquid chromatography (HPLC), Kjeldahl nitrogen determination, the phenol-sulfuric acid method, and enzyme-linked immunosorbent assay (ELISA). We employed human dermal fibroblasts (FB) to assess RRFA's anti-aging and antioxidative properties, immortalized keratinocytes (HaCaT cells) and 3D epidermal models to examine its moisturizing and reparative capabilities, and human primary melanocytes (MCs) to study its effects on skin lightening. Our findings revealed that RRFA encompasses several bioactive compounds beneficial for skin health. RRFA can significantly promote the proliferation of FB cells. And it markedly enhances the mRNA expression of ECM-related anti-aging genes and reduces reactive oxygen species production. Furthermore, RRFA significantly boosts the expression of Aquaporin 3 (AQP3), Filaggrin (FLG), and Hyaluronan Synthase 1 (HAS1) mRNA, alongside elevating moisture levels in a 3D epidermal model. Increases were also observed in the mRNA expression of Claudin 1 (CLDN1), Involucrin (IVL), and Zonula Occludens-1 (ZO-1) in keratinocytes. Additionally, RRFA demonstrated an inhibitory effect on melanin synthesis. Collectively, RRFA contains diverse ingredients which are beneficial for skin health and showcases multifaceted skincare effects in terms of anti-aging, antioxidant, moisturizing, repairing, and whitening capabilities in vitro, highlighting its potential for future cosmetic applications.


Sujet(s)
Aspergillus oryzae , Fermentation , Protéines filaggrine , Oryza , Aspergillus oryzae/métabolisme , Oryza/composition chimique , Oryza/métabolisme , Humains , Antioxydants/pharmacologie , Antioxydants/métabolisme , Kératinocytes/métabolisme , Kératinocytes/effets des médicaments et des substances chimiques , Cellules HaCaT , Fibroblastes/métabolisme , Fibroblastes/effets des médicaments et des substances chimiques , Mélanocytes/métabolisme , Mélanocytes/effets des médicaments et des substances chimiques , Hygiène de la peau/méthodes , Peau/métabolisme
19.
Front Immunol ; 15: 1386727, 2024.
Article de Anglais | MEDLINE | ID: mdl-38720888

RÉSUMÉ

Introduction: Vitiligo is an acquired de-pigmentation disorder characterized by the post-natal loss of epidermal melanocytes (pigment-producing cells) resulting in the appearance of white patches in the skin. The Smyth chicken is the only model for vitiligo that shares all the characteristics of the human condition including: spontaneous post-natal loss of epidermal melanocytes, interactions between genetic, environmental and immunological factors, and associations with other autoimmune diseases. In addition, an avian model for vitiligo has the added benefit of an easily accessible target tissue (a growing feather) that allows for the repeated sampling of an individual and thus the continuous monitoring of local immune responses over time. Methods: Using a combination of flow cytometry and gene expression analyses, we sought to gain a comprehensive understanding of the initiating events leading to expression of vitiligo in growing feathers by monitoring the infiltration of leukocytes and concurrent immunological activities in the target tissue beginning prior to visual onset and continuing throughout disease development. Results: Here, we document a sequence of immunologically significant events, including characteristic rises in infiltrating B and αß T cells as well as evidence of active leukocyte recruitment and cell-mediated immune activities (CCL19, IFNG, GZMA) leading up to visual vitiligo onset. Examination of growing feathers from vitiligo-susceptible Brown line chickens revealed anti-inflammatory immune activities which may be responsible for preventing vitiligo (IL10, CTLA4, FOXP3). Furthermore, we detected positive correlations between infiltrating T cells and changes in their T cell receptor diversity supporting a T cell-specific immune response. Conclusion: Collectively, these results further support the notion of cell-mediated immune destruction of epidermal melanocytes in the pulp of growing feathers and open new avenues of study in the vitiligo-prone Smyth and vitiligo-susceptible Brown line chickens.


Sujet(s)
Poulets , Modèles animaux de maladie humaine , Plumes , Mélanocytes , Vitiligo , Animaux , Vitiligo/immunologie , Poulets/immunologie , Plumes/immunologie , Mélanocytes/immunologie , Mélanocytes/métabolisme , Lymphocytes T/immunologie
20.
Front Biosci (Landmark Ed) ; 29(5): 194, 2024 May 20.
Article de Anglais | MEDLINE | ID: mdl-38812330

RÉSUMÉ

BACKGROUNDS: Melanogenesis, regulated by genetic, hormonal, and environmental factors, occurs in melanocytes in the basal layer of the epidermis. Dysregulation of this process can lead to various skin disorders, such as hyperpigmentation and hypopigmentation. Therefore, the present study investigated the effect of ultrasonic-assisted ethanol extract (SHUE) from Sargassum horneri (S. horneri), brown seaweed against melanogenesis in α-melanocyte-stimulating hormone (MSH)-stimulated B16F10 murine melanocytes. METHODS: Firstly, yield and proximate compositional analysis of the samples were conducted. The effect of SHUE on cell viability has been evaluated by using 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay. After that, the melanin content and cellular tyrosinase activity in α-MSH-stimulated B16F10 murine melanocytes were examined. Western blot analysis was carried out to investigate the protein expression levels of microphthalmia-associated transcription factor (MITF), tyrosinase, tyrosinase-related protein-1 (TRP1), and tyrosinase-related protein-2 (TRP2). In addition, the effect of extracellular signal-regulated kinase (ERK) on the melanogenesis process was assessed via Western blotting. RESULTS: As per the analysis, SHUE contained the highest average yield on a dry basis at 28.70 ± 3.21%. The findings showed that SHUE reduced the melanin content and cellular tyrosinase activity in α-MSH-stimulated B16F10 murine melanocytes. Additionally, the expression levels of MITF, TRP1, and TRP2 protein were significantly downregulated by SHUE treatment in α-MSH-stimulated B16F10 murine melanocytes. Moreover, SHUE upregulated the phosphorylation of ERK and AKT in α-MSH-stimulated B16F10 murine melanocytes. In addition, experiments conducted using the ERK inhibitor (PD98059) revealed that the activity of SHUE depends on the ERK signaling cascade. CONCLUSION: These results suggest that SHUE has an anti-melanogenic effect and can be used as a material in the formulation of cosmetics related to whitening and lightening.


Sujet(s)
Éthanol , Mélanines , Mélanocytes , Monophenol monooxygenase , Sargassum , Animaux , Sargassum/composition chimique , Mélanines/biosynthèse , Mélanines/métabolisme , Monophenol monooxygenase/métabolisme , Monophenol monooxygenase/antagonistes et inhibiteurs , Mélanocytes/effets des médicaments et des substances chimiques , Mélanocytes/métabolisme , Souris , Éthanol/composition chimique , Facteur de transcription associé à la microphtalmie/métabolisme , Hormone mélanotrope alpha/métabolisme , Extraits de plantes/pharmacologie , Extraits de plantes/composition chimique , Survie cellulaire/effets des médicaments et des substances chimiques , Mélanome expérimental/métabolisme , Lignée cellulaire tumorale , Intramolecular oxidoreductases/métabolisme
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...